Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-x5gtn Total loading time: 0 Render date: 2024-05-14T10:23:39.668Z Has data issue: false hasContentIssue false

Chapter 7 - Selecting the Best Donor for an Allogeneic Hematopoietic Cell Transplant

from Section 2 - Donor Selection for Allogeneic Hematopoietic Cell Transplants: A Moving Target

Published online by Cambridge University Press:  24 May 2017

By
Mary Eapen
Edited by
Hillard M. Lazarus ,
Robert Peter Gale ,
Armand Keating ,
Andrea Bacigalupo ,
Reinhold Munker  and
Kerry Atkinson
Edited in association with
Syed Ali Abutalib
Hillard M. Lazarus
Affiliation:
Case Western Reserve University, Ohio
Robert Peter Gale
Affiliation:
Imperial College London
Armand Keating
Affiliation:
University of Toronto
Andrea Bacigalupo
Affiliation:
Ospedale San Martino, Genoa
Reinhold Munker
Affiliation:
Louisiana State University, Shreveport
Kerry Atkinson
Affiliation:
University of Queensland
Syed Ali Abutalib
Affiliation:
Midwestern Regional Medical Center, Cancer Treatment Centers of America, Chicago
Get access
Type
Chapter
Information
Hematopoietic Cell Transplants
Concepts, Controversies and Future Directions
 , pp. 59 - 64
Publisher: Cambridge University Press
Print publication year: 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alousi, AM, Le-Rademacher, J, Saliba, RM, et al. Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer? Blood. 2013;121(13):2567–2773.Google Scholar
Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials. J Clin Oncol. 2005;23(22):5074–5087.Google Scholar
Schmitz, N, Eapen, M, Horowitz, MM, et al. Long-term outcome of patients transplanted with mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood. 2006;108:4288–4290.Google Scholar
Anasetti, C, Beatty, PG, Storb, R, et al. Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol. 1990;29(2):79–91.Google Scholar
Szydlo, R, Goldman, JM, Klein, JP, et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 1997;15(5):1767–1777.Google Scholar
Aversa, F, Tabilio, A, Velardi, A, et al. Treatment of high risk acute leukemia with T-cell depleted stem cells from related donors with one fully mismatched haplotype. N Eng J Med. 1998;339(17):1186–1193.Google Scholar
Ruggeri, L, Capanni, M, Urbani, E, Perruccio, K, Shlomchik, WD. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295(5562):2097–2100.Google Scholar
Luznik, L, O’Donnell, PV, Symons, HJ, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008;14(6):641–650.Google Scholar
Bashey, A, Zhang, X, Sizemore, CA, et al. T-Cell replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31(10):1310–1316.Google Scholar
Raiola, AM, Dominietto, A, Ghiso, A, et al. Unmanipulated haploidentical bone marrow transplantation and posttransplant cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biol Blood Marrow Transplant. 2013;19(1):117–122.Google Scholar
Di Bartolomeo, P, Santarone, S, De Angelis, G, et al. Haploidentical unmanipulated GCSF primed bone marrow transplantation for patients with high-risk hematologic malignancies. Blood. 2013;121(5):849–857.Google Scholar
Kasamon, YL, Luznik, L, Leffell, MS, et al. Nonmyeloablative HLA-haploidentical BMT with high-dose post-transplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transplant. 2010;16(4):482–489.Google Scholar
Huo, MR, Xu, L, Li, D, et al. The effect of HLA disparity on clinical outcome after HLA-haploidentical blood and marrow transplantation. Clin Transplant. 2012;26(2):284–291.Google Scholar
Morishima, Y, Sasazuki, T, Inoko, H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-DR matched unrelated donors. Blood. 2002;99(11):4200–4206.Google Scholar
Flomenberg, N, Baxter-Lowe, LA, Confer, D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104(7):1923–1930.Google Scholar
Lee, SJ, Klein, J, Haagenson, M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110(13):4576–4583.Google Scholar
Pidala, J, Lee, SJ, Ahn, KW, et al. Non-permissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood. 2014;124(16):2596–2606.Google Scholar
Woolfrey, A, Klein, JP, Haagenson, M, et al. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(6):885–892.CrossRefGoogle ScholarPubMed
Koreth, J, Ahn, KW, Pidala, J, et al. HLA-mismatch is associated with worse outcomes after unrelated donor reduced intensity hematopoietic cell transplantation: a CIBMTR analysis. Blood. 2013;122:547a.Google Scholar
Fleischhauer, K, Shaw, BE, Gooley, T, et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated donor haematopoietic cell transplantation: a retrospective study. Lancet Oncol. 2012;13(4):366–374.Google Scholar
Fernández-Viña, MA, Klein, JP, Haagenson, M, et al. Multiple mismatches at the low expression HLA loci DP, DQ, and DR3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation. Blood. 2013;121(22):4603–4610.Google Scholar
Beatty, PG, Mori, M, Milford, E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation. 1995;60(8):778–783.CrossRefGoogle ScholarPubMed
Kollman, C, Maiers, M, Gragert, L, et al. Estimation of HLA-A, -B, -DRB1 haplotype frequencies using mixed resolution data from a national registry with selective retyping of volunteers. Hum Immunol. 2007;68(12):950–958.CrossRefGoogle Scholar
Garget, L, Eapen, M, Williams, E, et al. HLA match likelihoods for unrelated donor grafts in the U.S. registry. N Engl J Med. 2014;371(4):339–348.Google Scholar
Eapen, M, Rocha, V, Sanz, G, et al. Effect of graft source on unrelated donor haematopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. Lancet Oncol. 2010;11(7):653–660.Google Scholar
Brunstein, CG, Gutman, JA, Weisdorf, DJ, et al. Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risk and benefits of double umbilical cord blood. Blood. 2010;116(22):4693–4699.Google Scholar
Brunstein, CG, Eapen, M, Ahn, KW, et al. Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes. Blood. 2012;119(23):5591–5598.CrossRefGoogle ScholarPubMed
Weisdorf, D, Eapen, M, Ruggeri, A, et al. Alternative donor hematopoietic transplantation for older patients with AML in first complete remission: a center for international blood and marrow transplant research-eurocord analysis. Biol Blood Marrow Transplant. 2014;20(6):816–822.Google Scholar
Brunstein, CG, Barker, JN, Weisdorf, DJ, et al. Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. Blood. 2007;110(8):3064–3070.Google Scholar
Scaradavou, A, Brunstein, CG, Eapen, M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013;121(5):752–758.Google Scholar
van Besien, K, Liu, H, Jain, N, Stock, W, Artz, A. Umbilical cord blood transplantation supported by third-party donor cells: rationale, results and applications. Biol Blood Marrow Transplant. 2013;19(5):682–691.Google Scholar
Liu, H, Rich, ES, Godley, L, et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GvHD and durable remission. Blood. 2011;118(24):6438–6445.Google Scholar
Delaney, C, Heimfeld, S, Brashem-Stein, C, Voorhies, H, Manger, RL, Bernstein, ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16(20):232–236.Google Scholar
de Lima, M, McNiece, I, Robinson, SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med. 2012;367(24):2305–2315.Google Scholar
Eapen, M, Klein, JP, Sanz, GF, et al. Effect of donor-recipient HLA matching at HLAA, B, C and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis. Lancet Oncol. 2011;12(13):1214–1221.Google Scholar
Eapen, M, Klein, JP, Ruggeri, A, et al. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy. Blood. 2014;123(1):133–140.Google Scholar
Myaskovsky, L, Switzer, GE, Dew, MA, Goycoolea, JM, Confer, DL, Abress, L. The association of donor center characteristics with attrition from the National Marrow Donor Registry. Transplantation. 2004;77(6):874–880.Google Scholar
Switzer, GE, Dew, MA, Goycoolea, JM, Myaskovsky, L, Abress, L, Confer, DL. Attrition of potential bone marrow donors at two key decision points leading to donation. Transplantation. 2004;77(10):1529–1534.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×